A team of Yale graduate students is gaining unique experience in how to launch a startup. Under the name Anthos Pharmaceuticals they are competing in the NIH Neuro Startup Challenge.

You can vote for your favotite team in the competition. To vote, go to this page. Voting has been extended to January 18.

Note: When you vote, it helps to leave a constructive comment, not just “great job,” etc. If you have already voted, you can still log back in and leave a comment now!

The Anthos team is pursuing a novel Alzheimer’s therapeutic that takes a new angle on treating the devastating disease by preventing hyperphosphorylation of Tau.

Please pass this message on to others who may be interested in voting.

The purpose of the competition is to accelerate the transfer of scientific innovation to the market by allowing teams to compete for access to NIH-held patents, while fostering business development. Over the course of the competition, teams craft their pitch, develop a business strategy, meet with potential investors, and incorporate their startup.